Nicotine	nicotine	CHEMICALS	O	OTHERS	I
potentiation	potentiation	O	O	O	O
of	of	O	O	O	O
morphine-induced	morphine-induced	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
in	in	O	O	O	O
mice	mice	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
mice	mice	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
investigated	investigated	O	O	O	O
.	.	O	O	O	O

Morphine	morphine	CHEMICALS	O	OTHERS	I
but	but	O	O	O	O
not	not	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
a	a	O	O	O	O
dose-dependent	dose-dependent	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
response	response	O	O	O	O
of	of	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
potentiated	potentiated	O	O	O	O
by	by	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Intraperitoneal	intraperitoneal	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
naloxone	naloxone	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
mecamylamine	mecamylamine	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
hexamethonium	hexamethonium	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
mice	mice	O	O	O	O
reduced	reduced	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
combination	combination	O	O	O	O
of	of	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
with	with	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Intracerebroventricular	intracerebroventricular	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
hexamethonium	hexamethonium	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
naloxone	naloxone	CHEMICALS	O	OTHERS	I
also	also	O	O	O	O
decreased	decreased	O	O	O	O
catalepsy	catalepsy	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
plus	plus	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Intraperitoneal	intraperitoneal	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
atropine	atropine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
intraperitoneal	intraperitoneal	O	O	O	O
or	or	O	O	O	O
intracerebroventricular	intracerebroventricular	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
hexamethonium	hexamethonium	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
decreased	decreased	O	O	O	O
the	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

It	it	O	O	O	O
was	was	O	O	O	O
concluded	concluded	O	O	O	O
that	that	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
catalepsy	catalepsy	O	DISEASE	OTHERS	I
can	can	O	O	O	O
be	be	O	O	O	O
elicited	elicited	O	O	O	O
by	by	O	O	O	O
opioid	opioid	O	O	O	O
and	and	O	O	O	O
cholinergic	cholinergic	O	O	O	O
receptors	receptors	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
potentiation	potentiation	O	O	O	O
of	of	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
also	also	O	O	O	O
be	be	O	O	O	O
mediated	mediated	O	O	O	O
through	through	O	O	O	O
cholinergic	cholinergic	O	O	O	O
receptor	receptor	O	O	O	O
mechanisms	mechanisms	O	O	O	O
.	.	O	O	O	O

